Mycophenolic Acid 霉酚酸 細(xì)胞代謝抑制劑:霉酚酸(Mycophenolic Acid,MPA),又名麥可酚酸,是一種免疫抑制劑,用來預(yù)防器管移置后的排斥反應(yīng)。MPA還具有抗真菌、抗細(xì)菌、抗病毒和抗腫瘤效應(yīng)。
Mycophenolic Acid (MPA) 霉酚酸(麥可酚酸)
Mycophenolic Acid (MPA) 霉酚酸;Immunosuppressive Drug 免疫抑制劑;Inosine monophosphatase dehydrogenase次黃嘌呤單核苷酸脫氫酶;IMPDH Inhibitor; Mycophenolate mofetil 嗎替麥考酚酯;CAS NO:24280-93-1;
產(chǎn)品信息
產(chǎn)品名稱 產(chǎn)品編號(hào) CAS NO. 規(guī)格 Mycophenolic Acid (MPA) 霉酚酸(麥可酚酸)MZ9231-0100MG
24280-93-1
100mg
Mycophenolic Acid (MPA) 霉酚酸(麥可酚酸) MZ9231-1000MG 24280-93-1 1g霉酚酸(Mycophenolic Acid,MPA),又名麥可酚酸,是一種免疫抑制劑,用來預(yù)防器guan移植后的排斥反應(yīng)。MPA的功能在其是一種有效且可逆的次黃嘌呤單核苷酸脫氫酶(IMPDH)抑制劑,淋巴細(xì)胞中能阻斷GTP的從頭合成并引起RNA和DNA合成的減少,從而防止淋巴細(xì)胞增殖和活化,并抑制抗體生成。MPA還具有抗真菌、抗細(xì)菌、抗病毒和抗腫瘤效應(yīng)。
產(chǎn)品特性
1) CAS NO:24280-93-1
2) 化學(xué)名:6-(1,3-Dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoic acid
3) 同義名:MPA; NSC 129185;
4) 分子式:C17H20O6
5) 分子量:320.34
6) 純度:≥98%
7) 外觀:白色或類白色粉末
8) 溶解性:溶于乙醇、甲醇、DMSO(30mg/ml)、不溶于水
注意事項(xiàng)
1) 本霉酚酸(MPA)不是臨床藥物,只能用于科研用途,不能用于診斷或臨床用途。
2) 為了您的安全和健康,請(qǐng)穿實(shí)驗(yàn)服并戴一次性手套操作。
使用方法
文獻(xiàn)1,Azzarone A et al. Effects on in vivo and in vitro hepatocyte proliferation of methylprednisolone, azathioprine, mycophenolic acid, mizoribine, and prostaglandin E1. Transplant Proc. 1992 Dec;24(6):2868-71. PMID: 1465977體外研究:
細(xì)胞類型(Cell type):Hepatocytes (from rat liver) in Primary Culture
藥物配制(Preparation):MPA was dissolved in DMSO
實(shí)驗(yàn)方法(Assay):MPA was dissolved in DMSO and added in the appropriate concentrations (0.6, 1.2, 2.4, 5, 10 μg/ml). The amount of DMSO added to the medium was never more than 2 μL/mL, which does not affect hepatocyte proliferation. The in vitro DNA synthesis was detected by [3H] Thymidine Incorporation.
體內(nèi)研究:
動(dòng)物模型(Animal Model):70% partial hepatectomy rat model
藥物配制(Preparation):MPA was dissolved in 0.5% carbossil-methil-cellulose (CMC), 0.4% Tween, and 0.9% alcohol in saline.
注射劑量(Dosages):Rats were assigned to groups and treated for 4 days as controls or with MPA (15mg/kg). On the 4th day, between 0900 and 1030 hours, the rats received a standard 70% hepatectomy under light ether anesthesia. Food and drink were allowed immediay. Twenty-four hours after the hepatectomies, 185 × 10?4 Bq [3H] thymidine was administered to all rats by intraperitoneal injection.
給藥途徑(Administration):Oral (p.o.)
相關(guān)產(chǎn)品
貨號(hào) 名稱 規(guī)格MZ9231-0100MG
Mycophenolic Acid (MPA) 霉酚酸(麥可酚酸) 100mgMZ9232-0100MG
Mycophenolate mofetil 嗎替麥考酚酯 100mgMycophenolic Acid 霉酚酸 細(xì)胞代謝抑制劑
Mycophenolic Acid 霉酚酸 細(xì)胞代謝抑制劑